Alterations in QT Interval in Patients Undergoing Living Donor Liver Transplantation

被引:38
|
作者
Shin, W. -J. [1 ]
Kim, Y. -K. [1 ]
Song, J. -G. [1 ]
Kim, S. -H. [1 ]
Choi, S. -S. [1 ]
Song, J. -H. [2 ]
Hwang, G. -S. [1 ]
机构
[1] Univ Ulsan, Coll Med, Dept Anesthesiol & Pain Med, Asan Med Ctr, Seoul 138736, South Korea
[2] Inha Univ, Coll Med, Dept Anesthesiol & Pain Med, Inchon, South Korea
关键词
TORSADES-DE-POINTES; CIRRHOTIC-PATIENTS; PROLONGATION; DISEASE; STAGE; DYSFUNCTION; SEVERITY; ETIOLOGY;
D O I
10.1016/j.transproceed.2010.12.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. QT interval prolongation, predisposing to ventricular tachyarrhythmia, has frequently been observed in patients with liver cirrhosis. During liver transplantation (LT) surgery, electrolyte imbalance and hemodynamic instability may affect QT interval changes. We evaluated the alterations in QT parameters at each stage of LT surgery. Methods. We assessed 50 living donor LT recipients without overt heart disease for the corrected QT (QTc) and the interval from peak to the end of the T wave (Tp-e) automatically using Bazett's formula with LabChart software. QT parameters, laboratory and hemodynamic data were simultaneously collected in the following stages of LT: before anesthetic induction (baseline), pre-anhepatic, anhepatic, 1 hour postreperfusion, and after hepatic artery anastomosis. Recipients were allocated into 2 groups according to their baseline QTc: >= 440 versus <440 msec. Results. QTc progressively rose from the pre-anhepatic stage remaining prolonged in each stage of LT surgery compared with the baseline. In the anhepatic stage, 54% of recipients showed marked prolongation of QTc >= 500 msec (522 +/- 14), which indicated the potential for a fatal ventricular dysrhythmia: 77% and 36% in groups with QTc >= 440 and <440 msec, respectively. As opposed to changes in QTc, Tp-e in the anhepatic stage decreased significantly; however, it returned to the baseline level in the neohepatic stage. Conclusion. A prolonged QTc interval (>= 500 msec) was frequently observed throughout the procedure of LT, even among patients with baseline QTc <440 msec, emphasizing the importance of optimizing electrolyte balance and hemodynamic status to reduce greater risk of perioperative arrhythmias.
引用
收藏
页码:170 / 173
页数:4
相关论文
共 50 条
  • [1] Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation
    González, MG
    Hernandez-Madrid, A
    Lopez-Sanromán, A
    Candela, A
    Nuño, J
    Barcena, R
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2366 - 2367
  • [2] A Comparison of the Effects of Sevoflurane and Desflurane on Corrected QT Interval Prolongation in Patients Undergoing Living Donor Liver Transplantation: A Prospective Observational Study
    Min, J. J.
    Lee, J.
    Lee, H. -C.
    Ryu, H. -G.
    Shin, M.
    Kim, H. J.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 96 - 101
  • [3] Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation
    Kaido, T.
    Ogawa, K.
    Fujimoto, Y.
    Ogura, Y.
    Hata, K.
    Ito, T.
    Tomiyama, K.
    Yagi, S.
    Mori, A.
    Uemoto, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (06) : 1549 - 1556
  • [4] Hepatocellular carcinoma in patients undergoing living-donor liver transplantation
    Maetani, Yoji S.
    Ueda, Mikiko
    Haga, Hironori
    Isoda, Hiroyoshi
    Takada, Yasutsugu
    Arizono, Shigeki
    Hirokawa, Yuusuke
    Shimada, Kootaro
    Shibata, Toshiya
    Kaori, Togashi
    INTERVIROLOGY, 2008, 51 : 46 - 51
  • [5] Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation
    Kaido, T.
    Ogawa, K.
    Fujimoto, Y.
    Ito, T.
    Tomiyama, K.
    Mori, A.
    Ogura, Y.
    Uemoto, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 218 - 218
  • [6] Outcomes of Patients with Benign Liver Diseases Undergoing Living Donor versus Deceased Donor Liver Transplantation
    Li, Chuan
    Mi, Kai
    Wen, Tian Fu
    Yan, Lu Nan
    Li, Bo
    Yang, Jia Ying
    Xu, Ming Qing
    Wang, Wen Tao
    Wei, Yong Gang
    PLOS ONE, 2011, 6 (11):
  • [7] HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation
    Lin, Shu-Hsien
    Wu, Kun-Ta
    Wang, Chih-Chi
    Huang, Kuang-Tzu
    Chen, Kuang-Den
    Lin, Chih-Che
    Hsu, Li-Wen
    Chiu, King-Wah
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
  • [8] The Population Pharmacokinetics of Fentanyl in Patients Undergoing Living-Donor Liver Transplantation
    Jin, S-J
    Jung, J-Y
    Noh, M-H
    Lee, S-H
    Lee, E-K
    Choi, B-M
    Song, M-H
    Noh, G-J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (03) : 423 - 431
  • [9] Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation
    Isiklar, Aysun
    Safer, Umut
    Safer, Vildan Binay
    Yiyit, Nurettin
    CLINICAL NUTRITION, 2019, 38 (02) : 964 - 965
  • [10] Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation.
    Kaido, Toshimi
    Ogawa, Kohei
    Fujimoto, Yasuhiro
    Ito, Takashi
    Tomiyama, Koji
    Mori, Akira
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2013, 19 : S97 - S97